Skip to content

Ascentage Pharma

US · AAPG #3045 by market cap Listed 2025
11.97 -0.47 -3.78%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Ascentage Pharma

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Founded
2009
CEO
Dr. Dajun Yang, M.D.,PhD
Employees
767
Headquarters
Suzhou, Jiangsu, China
Fiscal year end
12-31
Website
ascentage.com

Company profile

Exchange
US
Symbol
AAPG
Market-cap rank
#3045
Listing date
2025-01-24
Market cap
1.12B
Float cap
868.55M
Shares out
93.39M
Float shares
72.56M

Sectors & themes

Biotechnology HK ADR Fractional Shares JP Chinese Concept

Browse all sectors & themes

Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.

Ascentage Pharma discussion 0 comments

Add a comment